Predilife (FRA:0GA) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:0GA Predilife SA FRA:0GA
37 GF Score
Price €1.69
GF Value €17.86
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Predilife FFO per Share?

FFO per Share only applies to REITs.

FRA:0GA
37GF Score
Predilife SA FRA:0GA
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Predilife (FRA:0GA) Overvalued in 2026?

Based on GuruFocus' analysis, Predilife stock appears to be undervalued. The current stock price of €1.69 is trading 90.6% below its estimated GF Value™ of €17.86. GuruFocus considers Predilife to be Possible Value Trap.

Key valuation signals for FRA:0GA:

  • FFO per Share:
  • GF Value™: €17.86 vs. price of €1.69 (90.6% below fair value)
  • GF Score™: 37/100 with 5 warning signs

No single metric tells the full story. See the FRA:0GA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Predilife Business Description

Other Exchanges ALPRE:France
Address 39 rue Camille Desmoulins, Villejuif, Villejuif, FRA, 94805
Predilife SA develops solutions for predictive medicine, combining medical techniques (genetic tests, medical imaging) and mathematical models with a large amount of statistical data, which allows each individual to define their risk profile for the occurrence of various serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.
37GF Score

Get the complete analysis for FRA:0GA

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.69
Price
€17.86
GF Value